Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Seattle Genetics, Inc. (SGEN)

« Back to company index

SGEN Chatter Timeline

Stock Ticker for SGEN

Most Active Tweeters for SGEN

UserTweets
@FlashAlert_me 13
@SweepCastApp 11
@Tickeron 9
@MarcJacksonLA 8
@InsiderAlerts4U 5

Recent Tweets for SGEN

SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $SGEN with our scanner on $150 CALL Expiring: 06/17/2022 worth 43K? Start Y… https://t.co/NYIXdlKSId
May 28th 2022, 5:05pm
Tickeron @Tickeron
$SGEN in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 9, 2022. View odds for this a… https://t.co/OMaLbzHwK1
May 27th 2022, 6:05pm
atimeywimey @atimeywimey
$SGEN 77.78% Profitability across 11 trades in 1 month. Profit Factor of 6.07 and rating is Bearish. Get started fo… https://t.co/UJNRkgyMs6
May 27th 2022, 1:05pm
MaiteMerenda @MaiteMerenda
$SGEN 73.08% Win rate on 32 trades in 1 month. Profit Factor of 2.61, rating is Bullish. ? Stock Trading Ideas by… https://t.co/balcyPAJnI
May 27th 2022, 11:05am
Interna44849650 @Interna44849650
$SGEN Top analyst price target today..... ? https://t.co/RFy0DoX5HQ
May 27th 2022, 12:05am
InsiderAlerts4U @InsiderAlerts4U
$SGEN: New Insider Filing on Seagen Inc.'s Chief Technical Officer VAUGHN B HIMES: https://t.co/4QAuwKmnFk
May 26th 2022, 11:05pm
day_trading_de @day_trading_de
SGEN (Seagen Inc.) ? #Insider #stock alert! ? #Sale on 2022-05-24 - $SGEN ??: HIMES VAUGHN B (Chief Technical Offic… https://t.co/VN6UDcDwBT
May 26th 2022, 10:05pm
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed] filed SEC form 4: Chief Technical Officer HIMES VAUGHN B: Disposed 10,866 of Common Stock at… https://t.co/xMKGI9glTJ
May 26th 2022, 10:05pm
FintelAlerts @FintelAlerts
Insider Vaughn B Himes reports selling 10,866 shares of $SGEN for a total cost of $1,486,376.51 https://t.co/9EZLYRMF4A
May 26th 2022, 10:05pm
MarcJacksonLA @MarcJacksonLA
$TAK $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/XxyEFmxUKE
May 26th 2022, 10:05pm
MarcJacksonLA @MarcJacksonLA
$SGEN $TAK ASCO: Seagen, Takeda think Adcetris can become a force as a lymphoma combo drug https://t.co/Vh359gpvkH
May 26th 2022, 10:05pm
otcdynamics @otcdynamics
$SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Ov… https://t.co/K85wSNk316
May 26th 2022, 9:05pm
StockNewsBot2 @StockNewsBot2
$TAK $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/snXysX7TLD
May 26th 2022, 9:05pm
FastestAlert @FastestAlert
$TAK $SGEN Takeda And Seagen To Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/WQ4juaNoqG
May 26th 2022, 9:05pm
stock_titan @stock_titan
$TAK $SGEN Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement… https://t.co/4Nw9ia0VHz
May 26th 2022, 9:05pm
atimeywimey @atimeywimey
$SGEN 73.08% Profitability across 32 trades in 1 month. Profit Factor of 2.61 and rating is Bullish. Get started fo… https://t.co/wLnniIGvrl
May 26th 2022, 2:05pm
ShortAlgoTrades @ShortAlgoTrades
$SGEN Trading Ideas | Awaiting Buy signal. 85.71% Profitability based on 7 trades. Profit factor is 10.74. Learn mo… https://t.co/n3CxF5xbTo
May 26th 2022, 10:05am
stockresearchhq @stockresearchhq
Seagen Inc's quarterly revenue growth rate YoY of 28.50% ranked 1325 out of 5721 companies in our database. https://t.co/azm50ywSNm $SGEN
May 25th 2022, 11:05am
MarcJacksonLA @MarcJacksonLA
$SGEN Tucatinib Plus Trastuzumab Yields Positive Topline Data in Phase 2 MOUNTAINEER Trial for HER2+ mCRC… https://t.co/jvAsT94jVb
May 24th 2022, 10:05pm
MarcJacksonLA @MarcJacksonLA
$SGEN JMP Securities Reiterates Seagen Buy Rating, $157 PT https://t.co/xKruSlBFiq
May 24th 2022, 7:05pm
SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $SGEN with our scanner on $195 CALL Expiring: 09/16/2022 worth 163K? Start… https://t.co/LfM6vIhBJc
May 24th 2022, 6:05pm
BertrandBio @BertrandBio
@JacobPlieth I am not sure for $SGEN, but I think that $ALLO began dosing with their CAR-T with niro since data are… https://t.co/bg195ye1lP
May 24th 2022, 1:05pm
JacobPlieth @JacobPlieth
Has this $SWTX $SGEN BCMA combo trial begun yet? https://t.co/9fAcOFqmSs
May 24th 2022, 1:05pm
SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $SGEN with our scanner on $195 CALL Expiring: 09/16/2022 worth 163K? Start… https://t.co/Bt2O7nlc25
May 24th 2022, 12:05pm
stockresearchhq @stockresearchhq
Seagen Inc's quarterly revenue growth rate YoY of 28.50% ranked 1326 out of 5724 companies in our database. https://t.co/azm50ywSNm $SGEN
May 24th 2022, 12:05am
Tickeron @Tickeron
$SGEN's price moved above its 50-day Moving Average on May 16, 2022. View odds for this and other indicators:… https://t.co/9XCcTQB8ir
May 23rd 2022, 5:05pm
Quantumup1 @Quantumup1
BofA $SGEN Buy$170: +VE MOUNTAINEER Data Supports Growth Thesis, featuring 38% ORR/12.4mos DoR. Promising data de-r… https://t.co/bilJux8C3F
May 23rd 2022, 4:05pm
newsfilterio @newsfilterio
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer $SGEN https://t.co/fgLtp62yqe
May 23rd 2022, 2:05pm
MarcJacksonLA @MarcJacksonLA
$SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/qpT12Ggbx8
May 23rd 2022, 1:05pm
john_bresnahan @john_bresnahan
RT @BullBearBres: $SGEN ?? Seagen Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Co…
May 23rd 2022, 12:05pm
BullBearBres @BullBearBres
$SGEN ?? Seagen Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib)… https://t.co/2KcBXtw7Lj
May 23rd 2022, 12:05pm
investor_feed @investor_feed
$SGEN 8-K Seagen (23 May, 8:11am) ? Other Events; Financial Statements and Exhibits https://t.co/upPv4Ptw8m #SGEN #8K #Seagen #News
May 23rd 2022, 12:05pm
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed] filed form 8-K on May 23, 08:11:02 https://t.co/CwIMUcMaP6
May 23rd 2022, 12:05pm
Market_Newswire @Market_Newswire
$SGEN SEC Filing: 8-K Other Events - Seagen Inc. (0001060736) May 23 https://t.co/AsCKJb7oH3
May 23rd 2022, 12:05pm
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed]: Issued Press Release on May 23, 08:00:00: Seagen Announces Positive Topline Results of Pivota… https://t.co/MFJtTvNhTB
May 23rd 2022, 12:05pm
StockNewsBot2 @StockNewsBot2
$SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/z5EISneT6j
May 23rd 2022, 12:05pm
hephaistos_ai @hephaistos_ai
RT @FastestAlert: $SGEN Seagen Announces Positive Topline Results Of Pivotal Phase 2 Clinical Trial Of TUKYSA® (tucatinib) In Combination W…
May 23rd 2022, 12:05pm
FastestAlert @FastestAlert
$SGEN Seagen Announces Positive Topline Results Of Pivotal Phase 2 Clinical Trial Of TUKYSA® (tucatinib) In Combina… https://t.co/14GI4kdZGa
May 23rd 2022, 12:05pm
WebChronicleTo1 @WebChronicleTo1
$SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/UvSy0exvay
May 23rd 2022, 12:05pm
hephaistos_ai @hephaistos_ai
RT @stock_titan: $SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combination Wi…
May 23rd 2022, 12:05pm
stock_titan @stock_titan
$SGEN Seagen Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUKYSA® (tucatinib) in Combina… https://t.co/MPNYa2wwUe
May 23rd 2022, 12:05pm
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in SEATTLE GENETICS $SGEN https://t.co/afZfV4OPyf
May 22nd 2022, 6:05am
Tickeron @Tickeron
$SGEN in Uptrend: price may jump up because it broke its lower Bollinger Band on May 9, 2022. View odds for this an… https://t.co/UGZ3WClfei
May 20th 2022, 3:05pm
Tickeron @Tickeron
$SGEN was the market's top quarterly gainer, rising +15.17% #Seagen https://t.co/cRZAvUOamw
May 20th 2022, 2:05am
Tickeron @Tickeron
$SGEN's price moved above its 50-day Moving Average on May 16, 2022. View odds for this and other indicators:… https://t.co/YBb84GXcBy
May 20th 2022, 1:05am
FlashAlert_me @FlashAlert_me
$SGEN [15s. delayed] filed form 8-K on May 19, 16:47:55 https://t.co/5kmnNVOL0d
May 19th 2022, 8:05pm
investor_feed @investor_feed
$SGEN 8-K Seagen (19 May, 4:47pm) ? Submission of Matters to a Vote of Security Holders… https://t.co/HYEvJmU6dZ
May 19th 2022, 8:05pm
SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $SGEN with our scanner on $140 CALL Expiring: 09/16/2022 worth 40K? Start Y… https://t.co/QZVPYL2l0b
May 19th 2022, 1:05pm
SweepCastApp @SweepCastApp
SweepCast ? Unusual Options Observed : $SGEN with our scanner on $145 PUT Expiring: 06/17/2022 worth 66K? Start Yo… https://t.co/YimUOKvAkG
May 19th 2022, 3:05am
Tickeron @Tickeron
$SGEN in Uptrend: price expected to rise as it breaks its lower Bollinger Band on May 9, 2022. View odds for this a… https://t.co/Demiv4zAci
May 19th 2022, 2:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.